We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
A phase I study of vorinostat in combination with bortezomib in patients with advanced malignancies.
- Authors
Schelman, William R; Traynor, Anne M; Holen, Kyle D; Kolesar, Jill M; Attia, Steven; Hoang, Tien; Eickhoff, Jens; Jiang, Zhisheng; Alberti, Dona; Marnocha, Rebecca; Reid, Joel M; Ames, Matthew M; McGovern, Renee M; Espinoza-Delgado, Igor; Wright, John J; Wilding, George; Bailey, Howard H
- Abstract
A phase I study to assess the maximum-tolerated dose (MTD), dose-limiting toxicity (DLT), pharmacokinetics (PK) and antitumor activity of vorinostat in combination with bortezomib in patients with advanced solid tumors.
- Publication
Investigational new drugs, 2013, Vol 31, Issue 6, p1539
- ISSN
1573-0646
- Publication type
Journal Article
- DOI
10.1007/s10637-013-0029-6